Liberalised German market "to provide spur for medtech"
This article was originally published in Clinica
Executive Summary
BVMed industry association chairman Anton Schmidt (Johnson & Johnson) believes that a deregulated and liberalised healthcare market, with bureaucracy cut away, would provide optimum conditions for the introduction of more medical technology innovations.